Three-Part Medtech Innovation Equation: The Thoracic Surgeon’s View
Executive Summary
Medtech advancements leading to cost savings and improved outcomes are the result of a confluence of three elements: technology, clinical processes, and the business case, according to consultant thoracic surgeon Aman Coonar.
You may also be interested in...
Intuitive’s da Vinci: Will Familiarity Breed Success?
Robotic soft-tissue MIS pioneer Intuitive Surgical continues to advance its offering in this disruptive area of medical technology. Having weathered an adverse incident-related storm, it is putting efforts into driving OUS business, broadening surgical applications, and convincing the doubters about robotic surgery’s place and role in the catalog of care delivery.
UK LifeSci Funding Boost – Medtech Research And Regulation To Benefit
Rebranded Health Innovation Networks, Biobanks and clinical trials get share of £650m UK funding earmarked to support research, manufacturing, skills development and access to diagnosis and treatment.
UK Pro-Innovation Report Offers Promise For Medtech With MHRA/NICE Alignment
Report to government underlines need for faster, parallel evaluation of medtech and healthtech innovation and recommends bigger role for MHRA alongside work done by approved bodies on UKCA file processing.